Angelini Industries

What Angelini Industries does

Angelini Industries is a privately held Italian industrial holding company founded in 1919 and headquartered in Rome, operating across three core segments: Health (77% of 2024 revenue), Industrial Technology (14%), and Consumer Goods (9%). The Health segment is led by Angelini Pharma, which researches, develops, and markets pharmaceuticals focused on Brain Health (mental health and epilepsy), Consumer Healthcare, Specialty Care, and Primary Care, with recent expansion into US specialty/rare-disease markets via the announced Catalyst Pharmaceuticals acquisition and a corporate venture capital arm (Angelini Ventures) managing approximately €300M in biotech and digital health assets. The Industrial Technology segment is operated through Angelini Technologies-Fameccanica, which designs automated production lines, converting equipment, and robotics for FMCG manufacturers, holding 1,200+ active patents and an installed base of 1,300 production plants across 72 countries; in 2026 it expanded into logistics robotics through a minority stake in US startup LAB0. The Consumer Goods segment is anchored by the 50/50 Fater joint venture with Procter & Gamble (personal care, home care, tissue products, and the newly transferred Amuchina and Infasil brands) and Angelini Wines & Estates (six wineries, ~4 million bottles annually).

Name

Angelini Industries

Legal name

Angelini Holding S.p.A.

Website

https://angeliniindustries.com

Company type

Private

Founded year

1919

Operating status

Operating

Headcount range

5,001–10,000 employees

Short description

Angelini Industries is a privately held Italian industrial group operating across Health (Angelini Pharma, Angelini Ventures), Industrial Technology (Angelini Technologies-Fameccanica), and Consumer Goods (Fater JV with P&G, Angelini Wines & Estates), serving pharmaceutical, FMCG manufacturer, and consumer retail markets across 21 countries.

Ownership category

akta.pro rank

Product category

Diversified Industrial Holdings (Pharmaceuticals, Industrial Automation, Consumer Goods)

NAICS

Computer and Electronic Product Manufacturing (334), Commercial and Service Industry Machinery Manufacturing (333310)

SIC

Search, Detection, Navagation, Guidance, Aeronautical Sys (3812), General Industrial Machinery & Equipment (3560)

akta.pro primary industry

Micro-VC & Angel Funds (FSANAAAI)

Keywords

• Pharmaceutical manufacturing
• Industrial automation systems
• Consumer personal care
• FMCG production machinery
• Healthcare venture capital

Headquarters

HQ city

Rome

HQ country

Italy

HQ region

Europe

Offices5 records

Markets served

GTM type

B2B and B2C

Offering type

Hardware or Manufacturing

Cost components

Personnel, Operations, Supply Chain, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Pharmaceutical Products: Research, development and marketing of health solutions through Angelini Pharma. Focus areas include Brain Health (Mental Health and Epilepsy), Consumer Healthcare, Specialty and Primary Care. Revenue from product sales to pharmacies, hospitals, and healthcare providers. Recent expansion into US market through Catalyst Pharmaceuticals acquisition.
2. Consumer Goods: Sale of consumer goods through Fater (50/50 JV with P&G) including personal care products, home care and tissue products. Also through Angelini Wines & Estates with 6 wineries producing approximately 4 million bottles annually. Brand transfer of Amuchina and Infasil from Angelini Pharma to Fater completed January 2026.
3. Industrial Technology Products and Services: Technologies, services for automation and industrial production of FMCG products, sustainable packaging and digital services for process optimization through Angelini Technologies (Fameccanica). Converting and Automation & Robotics are the two main operating areas. Includes sale of production equipment and robotics systems globally.
4. Corporate Venture Capital: Angelini Ventures invests in biotech and digital health startups. €300 million in assets under management. Recent investments include €150M fund with European Investment Bank backing 10 European health tech startups including Laigo Bio, CoMind, and Adcytherix.

Go-to-market motion3 records

Distribution channels4 records

Marketing channels10 records

Core offering

Angelini Industries is a diversified Italian industrial holding company that researches, develops, manufactures, and sells pharmaceutical products (brain health, mental health, epilepsy, consumer healthcare, specialty and primary care) through Angelini Pharma, industrial automation equipment and robotics for FMCG manufacturers through Angelini Technologies (Fameccanica), and consumer personal care/home care products plus premium wines through wholly-owned subsidiaries and joint ventures. The group operates across Health, Consumer Goods, and Industrial Technology sectors with 5,600 employees and €1.59 billion in 2024 revenue.

Product overview

Angelini Industries is a diversified Italian industrial group operating across three core business sectors: Health (pharmaceuticals and biotech venture capital), Consumer Goods (personal care products and wines), and Industrial Technology (automation and robotics). The company operates through a portfolio structure including wholly-owned divisions (Angelini Pharma, Angelini Technologies-Fameccanica) and joint ventures (Fater with P&G, Angelini Wines & Estates, MadreNatura with Hero Group). Angelini Pharma focuses on Brain Health solutions including mental health and epilepsy treatments, while Angelini Technologies-Fameccanica provides industrial automation solutions with over 1,200 patents. The Group also maintains Angelini Ventures for biotech/digital health investments and Angelini Academy for corporate training programs.

Differentiator

Problem solved

Functional benefit

Brands

• Angelini Pharma: Pharmaceutical company researching, developing and marketing health solutions with focus on Brain Health, Mental Health, Epilepsy, Consumer Healthcare, Specialty and Primary Care
• Angelini Ventures
• Angelini Technologies
• Fameccanica
• Fater
• Angelini Wines & Estates
• MadreNatura
• Angelini Academy
• Greenpackt
• Glueless

Products and services

• Angelini Pharma Pharmaceutical Products Pharmaceutical products focused on Brain Health (Mental Health and Epilepsy), Consumer Healthcare, Specialty and Primary Care. Sold to pharmacies, hospitals, and healthcare providers globally, with recent US market entry through Catalyst Pharmaceuticals acquisition. Includes partnerships with Sovargen, GRIN Therapeutics, and JCR Pharmaceuticals for pipeline development.
• Angelini Technologies (Fameccanica) Industrial Automation Systems Automated production lines, converting machinery, and robotics systems for FMCG manufacturers globally. Two main operating areas: Converting and Automation & Robotics. Backed by 1,200+ active patents and 1,300 production plants installed in 72 countries. Customers include manufacturers of absorbent hygiene products and consumer goods.
• Greenpackt Sustainable Packaging System Patented, integrated, and environmentally-friendly sustainable packaging system developed by Angelini Technologies - Fameccanica. Represents the company's commitment to green innovation for FMCG manufacturers.
• Glueless Technology Ultrasonic welding technology that reduces the use of glue in production processes for absorbent hygiene products. Improves both products and production processes through sustainable manufacturing methods.
• Fater Consumer Personal Care and Home Care Products Consumer personal care products, home care products, and tissue products sold through the 50/50 Fater joint venture with Procter & Gamble. Leader in Italian personal care market and key European player in home care and tissue products. Now manages Amuchina and Infasil brands following transfer from Angelini Pharma effective January 2026.
• Angelini Wines & Estates Premium Italian Wines Premium Italian wines produced across 6 wineries with 1,700 hectares of land (including 460 hectares of vineyards), producing approximately 4 million bottles annually. Includes renowned brands such as Bertani (awarded Wine of the Year 2024 by James Suckling with 100 points) and Sant'Andrea. Distributed through wine merchants and restaurants.
• MadreNatura Baby Food Products Healthy and balanced baby food products provided through the 50/50 MadreNatura joint venture between Angelini Industries and Hero Group, founded in 2019. Combines knowledge of both parent companies to deliver nutritious food programs for children.

Quantifiable outcome

• Revenue growth of +2.8% to €1.59 billion in 2024
• +3 more outcomes

Named customers4 records

Segments4 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability2 records

Feature6 records

Partnerships

Eleven partnerships are on record, tiered minor, core and strategic.

• SovargenminorStrategic or Co-development PartnerPharmaceutical partnership to strengthen Angelini Pharma's Brain Health pipeline.
• GRIN TherapeuticsminorStrategic or Co-development PartnerPharmaceutical partnership to strengthen Angelini Pharma's pipeline in specialty care.
• JCR PharmaceuticalscoreStrategic or Co-development PartnerGlobal collaboration for development and commercialization of novel biologic therapies for epilepsy treatment.
• LAB0strategicTechnology or IntegrationAngelini Technologies acquired minority stake in American startup LAB0 to develop robotic systems for automated loading and unloading of parcels from containers and trucks. Target market estimated at $8 billion by 2030. Angelini Technologies opening new Boston office with 25 robotics and engineering professionals.
• Procter & GamblecoreChannel Partner/ Reseller/ Distributor50/50 joint venture Fater between Angelini Industries and P&G, leader in Italian personal care market and key European player in home care and tissue products. Joint venture operational since 1990s, celebrating 30 years in 2022.
• Hero GroupminorChannel Partner/ Reseller/ DistributorEqual joint venture MadreNatura founded in 2019, combining knowledge of Angelini Industries and Hero Group to offer healthy, balanced food programs for children.
• Give Back BeautyminorChannel Partner/ Reseller/ DistributorGive Back Beauty acquired AB Parfums (formerly Angelini Beauty) from Angelini Industries. AB Parfums distributes fragrances including Trussardi, Laura Biagiotti, and L'Oréal brands. Angelini Industries divested to focus on pharmaceuticals and industrial technology.
• IE Business SchoolstrategicStrategic or Co-development PartnerAngelini Academy Gateway partnership offering 10 young professionals opportunity to participate in Full-Time International MBA at IE University in Madrid. Specialized modules in Life Sciences and Industrial Robotics delivered by Angelini Academy.
• FatercoreChannel Partner/ Reseller/ Distributor50/50 joint venture receiving transfer of Amuchina and Infasil brands from Angelini Pharma effective January 2026. Fater is leader in Italian personal care and key player in European home care market.
• Valore DminorStrategic or Co-development PartnerAngelini Pharma partnership with Valore D, organization promoting gender equality within organizations in Italy, enabling network exchange and best practice sharing.
• Accademia Nazionale di Santa CeciliaminorStrategic or Co-development PartnerCultural partnership for 'Prove d'Ascolto' (Listening Tests) project bringing young people to orchestral rehearsals, promoting mental health awareness through music.

Scale indicators14 records

Recent moves6 records

Expansion highlights6 records

Regional players

• Zambon S.p.A. Italian privately-held pharma group focused on respiratory, CNS, and rare diseases. Comparable as an Italian mid-sized family-controlled pharma with similar therapeutic area focus to Angelini Pharma.

Direct peers

• Bayer AG: German multinational pharma and consumer health conglomerate with Crop Science and Consumer Health divisions — closely parallels Angelini's multi-vertical structure spanning pharma, consumer goods, and a third industrial-adjacent business.
• Chiesi Farmaceutici S.p.A. Italian family-owned (Chiesi family) global pharmaceutical company focused on respiratory, neonatology, and rare diseases. Comparable as a privately-held Italian pharma with specialty-care focus and international expansion.
• Merck KGaA: German family-controlled (E. Merck) science and technology group operating across Healthcare, Life Science, and Electronics — the closest peer in terms of family ownership, diversified pharma+industrial structure, and German/European roots.
• Menarini Group: Italian privately-held pharma company with international footprint spanning prescription drugs, diagnostics, and consumer health. Comparable as a privately-held Italian pharma with international ambitions.
• Coesia S.p.A. Italian privately-held group of industrial and packaging solutions companies serving FMCG manufacturers. Comparable to Angelini Technologies-Fameccanica in industrial automation for consumer goods production.
• IMA Group: Italian manufacturer of packaging machinery and automation for the pharma and FMCG industries — directly comparable to Fameccanica/Angelini Technologies in converting/automation for FMCG and pharma customers.
• Recordati S.p.A. Italian specialty pharma group focused on rare diseases and selected therapeutic areas. Comparable in geography, Italy-headquartered pharma operations, and a recent US growth push through specialty acquisitions.

Broad incumbents

• Sanofi S.A. Global pharma major with a Specialty Care franchise overlapping Angelini Pharma's Brain Health and rare disease focus. Larger scale and broader portfolio but operates in the same therapeutic areas.
• Boehringer Ingelheim: Family-owned German global pharma company. Comparable governance (family-controlled), European heritage, and specialty pharma focus including CNS and rare diseases — overlapping with Angelini Pharma's Brain Health priorities.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

• YouTubeyoutube.com/@meetangeliniindustries9936
• Facebookfacebook.com/MeetAngeliniIndustries
• LinkedInlinkedin.com/company/angelini-industries
• Instagraminstagram.com/angelini.industries
• Xx.com/AngeliniPharma

Compliance5 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles7 records

Subsidiaries8 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Angelini Industries